Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment

D. Darsova, P. Pochop, J. Uhlik, E. Klapkova, H. Tesfaye, D. Kodetova, J. Lestak, J. Malis, L. Vajner

. 2012 ; 156 (4) : 318-323.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14049942

AIM: To determine intravitreal and plasma concentrations and retinal toxicity after transcorneal intravitreal injection of 1 μg and 2 μg of topotecan (Hycamtin). METHOD: Twelve healthy albino rabbits were included in this in vivo experiment. Six anesthetized albino rabbits received a single transcorneal intravitreal injection of 1 μg (group A) or 2 μg (group B) of topotecan. Vitreous and blood samples were collected until 168 h. Left eyes were treated with the same volume of saline. Plasma and vitreous levels of topotecan were determined by high-performance liquid chromatography. Area under the plasma concentration time curve (AUC) was calculated using trapezoidal rule. Clinical evidence of toxicity was classified into four grades according to anatomical structures. Electroretinograms (ERGs) were recorded. RESULTS: Time to maximum concentration was observed up to 2 h after drug injection in group A whereas up to 1 h in group B. Low levels of topotecan were detected in plasma in both groups and in the vitreous humor of the contralateral eye in group B. Topotecan levels (mean vitreous AUC in group A 2.55 μg/mL.h and in group B 5.338 μg/mL.h) were detectable up to 6 h in both groups. We observed following structural changes in rabbit eyes: corneal vascularization, cataract, hemophthalmus, choroidal edema and focal retinal atrophy. Abnormal ERGs were obtained. CONCLUSION: Our findings proved that transcorneal intravitreal administration of 1 μg and 2 μg of topotecan results in potentially cytotoxic intraocular concentrations. More studies are needed to establish the safety of topotecan for retinoblastoma in children.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14049942
003      
CZ-PrNML
005      
20140328100056.0
007      
ta
008      
140325s2012 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2011.068 $2 doi
035    __
$a (PubMed)22660213
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Petrušková, Denisa $u Department of Ophthalmology for Children and Adults, Charles University 2nd Faculty of Medicine and Motol Hospital, Prague $7 xx0173311
245    10
$a Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment / $c D. Darsova, P. Pochop, J. Uhlik, E. Klapkova, H. Tesfaye, D. Kodetova, J. Lestak, J. Malis, L. Vajner
520    9_
$a AIM: To determine intravitreal and plasma concentrations and retinal toxicity after transcorneal intravitreal injection of 1 μg and 2 μg of topotecan (Hycamtin). METHOD: Twelve healthy albino rabbits were included in this in vivo experiment. Six anesthetized albino rabbits received a single transcorneal intravitreal injection of 1 μg (group A) or 2 μg (group B) of topotecan. Vitreous and blood samples were collected until 168 h. Left eyes were treated with the same volume of saline. Plasma and vitreous levels of topotecan were determined by high-performance liquid chromatography. Area under the plasma concentration time curve (AUC) was calculated using trapezoidal rule. Clinical evidence of toxicity was classified into four grades according to anatomical structures. Electroretinograms (ERGs) were recorded. RESULTS: Time to maximum concentration was observed up to 2 h after drug injection in group A whereas up to 1 h in group B. Low levels of topotecan were detected in plasma in both groups and in the vitreous humor of the contralateral eye in group B. Topotecan levels (mean vitreous AUC in group A 2.55 μg/mL.h and in group B 5.338 μg/mL.h) were detectable up to 6 h in both groups. We observed following structural changes in rabbit eyes: corneal vascularization, cataract, hemophthalmus, choroidal edema and focal retinal atrophy. Abnormal ERGs were obtained. CONCLUSION: Our findings proved that transcorneal intravitreal administration of 1 μg and 2 μg of topotecan results in potentially cytotoxic intraocular concentrations. More studies are needed to establish the safety of topotecan for retinoblastoma in children.
650    _2
$a zvířata $7 D000818
650    _2
$a králíci $7 D011817
650    _2
$a retina $x účinky léků $7 D012160
650    _2
$a nádory sítnice $x farmakoterapie $7 D019572
650    _2
$a retinoblastom $x farmakoterapie $7 D012175
650    _2
$a inhibitory topoisomerasy I $x aplikace a dávkování $x analýza $x krev $7 D059004
650    _2
$a topotekan $x aplikace a dávkování $x analýza $x krev $7 D019772
650    _2
$a sklivec $x chemie $7 D014822
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pochop, Pavel $u Department of Ophthalmology for Children and Adults, Charles University 2nd Faculty of Medicine and Motol Hospital, Prague $7 xx0142580
700    1_
$a Uhlík, Jiří, $u Department of Histology and Embryology, Charles University 2nd Faculty of Medicine, Prague $d 1966- $7 jn20010309782
700    1_
$a Klapková, Eva $u Department of Clinical Biochemistry and Pathobiochemistry, Charles University 2nd Faculty of Medicine and Motol Hospital, Prague $7 pna2011626059
700    1_
$a Tesfaye, Hundie $u Department of Clinical Biochemistry and Pathobiochemistry, Charles University 2nd Faculty of Medicine and Motol Hospital, Prague $7 xx0107277
700    1_
$a Nováková Kodetová, Daniela, $u Department of Pathology and Molecular Medicine, Charles University 2nd Faculty of Medicine and Motol Hospital, Prague $d 1953- $7 jo2002104665
700    1_
$a Lešták, Ján, $u Department of Ophthalmology, Clinic of Jan Lestak, Prague $d 1955- $7 xx0057880
700    1_
$a Mališ, Josef $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and Motol Hospital, Prague $7 xx0061186
700    1_
$a Vajner, Luděk, $u Department of Histology and Embryology, Charles University 2nd Faculty of Medicine, Prague $d 1954- $7 jn20010309783
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 156, č. 4 (2012), s. 318-323
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20140325 $b ABA008
991    __
$a 20140326150324 $b ABA008
999    __
$a ok $b bmc $g 1017414 $s 848512
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 156 $c 4 $d 318-323 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20140325

Najít záznam

Citační ukazatele

Možnosti archivace